Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit clarivate.com.
External link for Clarivate
Clarivate reposted this
We are excited to announce we are partnering with Iprova to streamline the invention creation and submission process! By integrating Iprova’s AI-powered product suite with IPfolio, the industry-leading #IP management software, we’re making it easier for organizations to capture, refine and transition ideas into the patent workflow. Learn more in the press release. https://lnkd.in/esR64E3r #IntellectualProperty #ArtificialIntelligence #AIinIP
Our Colleagues from NCR volunteering team partnered with Smile Foundation to organize a health check-up camp for underprivileged communities. The initiative focused on raising awareness about menstrual hygiene, empowering young girls with essential health knowledge, and breaking the stigma around menstruation. This collaboration reflects our ongoing commitment to social responsibility and making a meaningful impact in the communities we serve. At Clarivate, every colleague is entitled to 40 hours of paid volunteer time annually, providing an opportunity to give back to the community and make a meaningful impact. Discover more about our commitment: https://lnkd.in/dzauvjVa #Volunteering #SmileFoundation
The Top 100 Global Innovators 2025 list is out now. Discover the organizations setting the standard for excellence in innovation. “Being recognized as a Top 100 Global Innovator is a remarkable achievement given the pace of change – since 2000, we’ve seen an 80-fold increase in the volume of inventions. Competition is more global than ever before, and developments in one region can have a significant global impact. Hyperconnectivity and technological convergence play a pivotal role in driving innovation. The Top 100 organizations target innovation at the deployment and diffusion of technology and knowledge.” - Gordon Samson, President, Intellectual Property, Clarivate What trends emerged this year? Find out in the report: https://lnkd.in/gqSsRSXV #ThinkForward #Innovation #IntellectualProperty #Top100Innovators
This #InternationalWomensDay, Clarivate is thrilled to celebrate the incredible women who drive innovation, leadership, and progress within the organization and beyond. But we know that real change takes more than just celebration—it takes action. Let’s come together to accelerate progress, break barriers, and unlock a future of limitless possibilities. Learn how you can get involved in making an impact: https://lnkd.in/dGX7T8X #IWD2025 #WomensHistoryMonth #AccelerateAction
55% of the organizations represented in last year’s Top 100 Global Innovators list came from two countries. Which countries will top the list this year? Find out on March 12: https://lnkd.in/d9hXUMiX
The innovation behind the invention: The screen you’re reading on is the result of 150 years of knowledge and research. Behind the modern OLED lies the chemistry and material science of compounds that emit specific colors, the electronic engineering of the LEDs and the fundamental principles of quantum physics governing electron behavior in semiconductors. Where will innovation take us next? Find out on March 12. https://lnkd.in/d9hXUMiX #ThinkForward #Top100Innovators
At Clarivate, sustainability is more than a goal – it's the essence of our business. We're committed to weaving ESG principles into our global culture and decision-making. Discover how we are achieving this: https://ow.ly/U81350VaeqE #sustainability #SDGs #ESG #UN
As a global leader in providing trusted data, analytics, and actionable insights, we empower organizations and individuals to discover, protect, and advance innovations. From patent research to scientific literature, we are at the forefront of shaping a smarter, more connected world. Whether academia, research, or business, we help make data-driven decisions that fuel success and spark breakthroughs. Discover more: https://ow.ly/Etsj50V7Hx4 #ThinkForward #Innovation
Could GSK-3536819 be the future of protecting against Invasive Meningococcal Disease (IMD)? This innovative vaccine targets five major strains of the bacteria, and with upcoming FDA approval, it could change how we prevent this serious illness. Interested to learn more? Read Clarivate's 12th annual "Drugs to Watch" report: https://lnkd.in/eNiVUti6
Could GSK-3536819 Be the Future of Meningococcal Disease Prevention? GSK plc's innovative GSK-3536819 vaccine candidate represents a significant advancement in the fight against invasive meningococcal disease (IMD). This groundbreaking 5-in-1 vaccine targets the five major groups of *Neisseria meningitidis* (A, B, C, W, and Y) responsible for the majority of IMD cases worldwide. In April 2024, the FDA accepted a Biologics License Application (BLA) for GSK-3536819, with a Prescription Drug User Fee Act (PDUFA) date set for February 14, 2025. It is anticipated that GSK’s pentavalent vaccine will compete with currently licensed MenACWY vaccines, such as Menveo® and MenQuadfi®, and also rival Pfizer’s pentavalent vaccine Penbraya™. Join Sukhvinder Singh, Lead Healthcare Research & Data Analyst at Clarivate, as he delves into the market potential and analysis of this transformative vaccine. Stay ahead in the healthcare landscape by exploring Clarivate’s 12th annual *Drugs to Watch* report, featuring GSK-3536819 and 10 other breakthrough therapies addressing critical challenges in obesity, oncology, gene therapy and more. Download the full report: https://lnkd.in/eNiVUti6 #DrugDiscovery #GeneTherapy #Oncology #Obesity #HealthcareInnovation #Regulatory #DrugsToWatch
【オンデマンドウェブセミナー：揺れ動く米国市場：共和党新政権は米国の医療市場をどう変えるのか】 第二次トランプ政権下で米国医療はどのように進むのか？ 米国の新政権において、共和党が僅差ではあるものの議会多数派になったことは、ドナルド・J・トランプ氏が大統領に就任することで、薬剤価格から医療提供まで、米国の医療に大きな変化をもたらす可能性があることを意味しています。 本オンデマンドウェブセミナーでは、医療政策、規制情報、マーケットアクセスに関するクラリベイトの専門家が、業界のリーダーが抱える次のような疑問に対するインサイトを共有します。 • トランプ政権下でFDAはどのようになるのか？ • 共和党はインフレ抑制法や医療費負担適正化法の一部を縮小、あるいは廃止するのか？ • メディケアアドバンテージは再び勢いを取り戻すのか？ • ヘルスケア業界のM&Aは急速に進んでいるのか？ • 連邦政府の資金援助が途絶えると遠隔医療サービスは衰退するのか？ • より保護主義的な米国の政策姿勢は、多国籍ライフサイエンス企業に何をもたらすのか？ *本オンデマンドウェブセミナーは英語での配信となりますが、併せて日本語のトランスクリプトをダウンロードしていただけます。 視聴はこちら: https://lnkd.in/g9Pa9Byn #LifeSciences #CommercialAnalytics #RealWorldData #Clarivate #DRG #healthcare #analytics
Each year, we honor and highlight the top 100 organizations whose research and innovation not only push the boundaries of possibility, but also set new standards in innovation. Stay tuned for the Top 100 Global Innovators 2025 list: https://lnkd.in/gdsa4fcw #Top100Innovators #Innovation #IntellectualProperty